Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 50 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Megan S.

United Kingdom

USD 50 /hr

I provide a high impact scientific editing service as native English speaker with expertise in the field of Medicine

Profile Summary

I have a PhD in chronic kidney disease and post-doctoral experience in diabetic kidney disease, cancer, and gene splicing. In addition, I am the Managing Director of a medical editing and writing company that operates on a freelance and contract basis. I have worked in academia for 12 years and have been working as a medical editor/writer for the last 10 years. I have experience editing 1000+ manuscripts and have helped authors to publish in high-impact journals, such as Nature, The NEJM, and The Lancet.

Subject Matter Expertise

• ☆ Human Biology
• ☆ Neurology
• ☆ Oncology
• ☆ Radiation Therapy
• ☆ Chemotherapy
• ☆ Surgical Oncology
• ☆ Pediatric Oncology
• ☆ Cardiovascular Disease
• ☆ Vascular Medicine
• ☆ Cardiovascular Disease Management
• ☆ Clinical Laboratory Science
• ☆ Anatomic Pathology
• ☆ Molecular Pathology
• ☆ Cancer Research
• ☆ Cancer Biology
• ☆ Carcinogenesis
• ☆ Musculoskeletal Oncology
• ☆ Neuro-Oncology

Services

• Writing

Writing Medical Writing, General Proofreading & Editing

Work Experience

Managing Director/owner

Megan Stevens Editing Limited

January 2014 - Present

Education

PhD

University of Bristol

September 2011 - December 2014

Certifications

• English Editing

  MDPI

  August 2022 - Present

Publications

JOURNAL ARTICLE

Ling Li, Zheng J, Stevens M, Oltean S (2022). A repositioning screen using an FGFR2 splicing reporter reveals compounds that regulate epithelial-mesenchymal transitions and inhibit growth of prostate cancer xenografts . Molecular therapy. Methods & clinical development.

Star E, Stevens M, Gooding C, Chris Smith, Li L, Ayine ML, Harper SJ, David O Bates, Sebastian Oltean (2021). A drug-repositioning screen using splicing-sensitive fluorescent reporters identifies novel modulators of VEGF-A splicing with anti-angiogenic properties . Oncogenesis.

Stevens M, Sebastian Oltean (2019). Modulation of the Apoptosis Gene Bcl-x Function Through Alternative Splicing . Frontiers in genetics.

Stevens M, Star E, Lee M, Innes E, Li L, Bowler E, Harper S, David O Bates, Sebastian Oltean (2019). The VEGF-A exon 8 splicing-sensitive fluorescent reporter mouse is a novel tool to assess the effects of splicing regulatory compounds <i>in vivo</i> . RNA biology.

Stevens M, Sebastian Oltean (2019). Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis . Cells.

Kikuchi R, Stevens M, Harada K, Sebastian Oltean, Murohara T (2018). Anti-angiogenic isoform of vascular endothelial growth factor-A in cardiovascular and renal disease . Advances in clinical chemistry.

Stevens M, Sebastian Oltean (2018). Assessment of Kidney Function in Mouse Models of Glomerular Disease . Journal of visualized experiments : JoVE.

Stevens M, Sebastian Oltean (2018). Modulation of VEGF-A Alternative Splicing as a Novel Treatment in Chronic Kidney Disease . Genes.

Megan Stevens, Neal CR, Andrew Salmon, David O Bates, Harper SJ, Sebastian Oltean (2017). VEGF-A₁₆₅ b protects against proteinuria in a mouse model with progressive depletion of all endogenous VEGF-A splice isoforms from the kidney . The Journal of physiology.

Stevens M, Sebastian Oltean (2016). Alternative Splicing in CKD . Journal of the American Society of Nephrology : JASN.

Sebastian Oltean, Qiu Y, Ferguson JK, Stevens M, Neal C, Russell A, Amit Kaura, Kenton Arkill, Harris K, Symonds C, et al. (2014). Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy . Journal of the American Society of Nephrology : JASN.